Ratings
0
Nobody has rated this yet. Be the first!
Works
2
Metabolism-directed optimization of 3-aminopyrazinone acetamide thrombin inhibitors. Development of an orally bioavailable series containing P1 and P3 pyridines
Discovery of potent, selective 4-fluoroproline-based thrombin inhibitors with improved metabolic stability
